|
EXOC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.62239999999381E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.642900E-04 |
| Normal-vs-Stage2 |
2.447800E-04 |
| Normal-vs-Stage3 |
7.50940000000533E-05 |
| Normal-vs-Stage4 |
1.395070E-04 |
| Stage1-vs-Stage2 |
1.352560E-01 |
| Stage1-vs-Stage3 |
1.939630E-01 |
| Stage1-vs-Stage4 |
2.484000E-01 |
| Stage2-vs-Stage3 |
6.159200E-01 |
| Stage2-vs-Stage4 |
7.353400E-01 |
| Stage3-vs-Stage4 |
8.845000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.78880000000814E-05 |
| Normal-vs-AfricanAmerican |
3.596100E-02 |
| Normal-vs-Asian |
6.238200E-02 |
| Caucasian-vs-AfricanAmerican |
6.260400E-01 |
| Caucasian-vs-Asian |
1.454440E-01 |
| AfricanAmerican-vs-Asian |
5.939000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.2827000000063E-05 |
| Normal-vs-Female |
1.360770E-04 |
| Male-vs-Female |
6.236000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.523000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.376490E-04 |
| Normal-vs-Age(61-80Yrs) |
4.6757999999647E-06 |
| Normal-vs-Age(81-100Yrs) |
2.042200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.823420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.214000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.888200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.147400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.860000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.611800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.697200E-01 |
| Classical-VS-Follicular |
8.151400E-04 |
| Classical-VS-Other |
8.580000E-01 |
| Classical-VS-Normal |
2.357000E-03 |
| Tall-VS-Follicular |
1.974160E-01 |
| Tall-VS-Other |
7.984000E-01 |
| Tall-VS-Normal |
7.635500E-03 |
| Follicular-VS-Other |
3.583600E-01 |
| Follicular-VS-Normal |
3.02740000002188E-06 |
| Other-VS-Normal |
2.029000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78446999999915E-05 |
| Normal-vs-N1 |
3.223300E-03 |
| N0-vs-N1 |
4.284800E-01 |
|
|
